КРИТЕРИИ ДИАГНОСТИКИ ПРЕДИАБЕТА У ДЕТЕЙ И ПОДРОСТКОВ С ОЖИРЕНИЕМ: ОБЗОР ЛИТЕРАТУРЫ

Олена Толстикова

doi:10.30888/2415-7538.2021-22-01-032

Автор(и)

Олена Толстикова Дніпровський державний медичний університет https://orcid.org/0000-0002-4952-1080

DOI:

https://doi.org/10.30888/2415-7538.2021-22-01-032

Ключові слова:

предіабет, діагностика, оральний глюкозо-толерантний тест, глікований гемоглобін, рівень глюкози натщесерце, діти, підлітки, огляд літератури.

Анотація

Анотація. Ожиріння в усьому світі продовжує зростання, у тому числі серед дітей та підлітків, набуваючи риси глобальної пандемії та призводячи до розвитку цукрового діабету. Предіабет, що передує діабету, визначають як концентрацію глюкози в крові, що пер

Metrics

Metrics Loading ...

Посилання

Агарков С.Ф., Толстикова Е.А. (2015) Сравнительная оценка липидограммы, лептин- и адипонектинемии у подростков и лиц молодого возраста с метаболическим синдромом. Здоровье ребенка. №7 (67). С. 93-96.

Толстікова, О.О., Агарков, С.Ф. (2019) Сучасні уявлення про метаболічний синдром у дітей та підлітків. Лікарська справа. Врачебное дело (№ 5/6). С. 27-39. ISSN 1019-5297.

American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012; 35: S 64–71.

Amed S, Oram R. Maturity-Onset Diabetes of the Young (MODY): Making the right diagnosis to optimize treatment. Can J Diabetes 2016; 40:449–54.

De Franco E, Flanagan SE, Houghton JA, et al. The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: An international cohort study. Lancet 2015; 386:957–63.

Shields BM, Peters JL, Cooper C, et al. Can clinical features be used to differentiate type 1 from type 2 diabetes? A systematic review of the literature. BMJ Open 2015;5: e009088.

Fatima A, Khawaja KI, Burney S, et al. Type 1 and type 2 diabetes mellitus: Are they mutually exclusive? Singapore Med J 2013; 54:396–400.

Naylor R, Philipson LH. Who should have genetic testing for maturity-onset diabetes of the young? Clin Endocrinol (Oxf) 2011; 75:422–6.

Jones AG, Hattersley AT. The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet Med 2013; 30:803–17.

Redondo MJ, Rodriguez LM, Escalante M, et al. Types of pediatric diabetes mellitus defined by anti-islet autoimmunity and random C-peptide at diagnosis. Pediatr Diabetes 2013; 14:333–40.

Oram RA, Patel K, Hill A, et al. A type 1 diabetes genetic risk score can aid dis-crimination between type 1 and type 2 diabetes in young adults. Diabetes Care2016; 39:337–44.

Sacks DB, Arnold M, Bakris GL, et al. Executive summary: Guidelines and rec-ommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2011; 57:793–8.

Nakagami T, Takahashi K, Suto C, et al. Diabetes diagnostic thresholds of the glycated hemoglobin A1c and fasting plasma glucose levels considering the 5-year incidence of retinopathy. Diabetes Res Clin Pract 2017; 124:20–9.

Sabanayagam C, Khoo EY, Lye WK, et al. Diagnosis of diabetes mellitus using HbA1c in Asians: Relationship between HbA1c and retinopathy in a multiethnic Asian population. J Clin Endocrinol Metab 2015; 100:689–96.

Ito C. Evidence for diabetes mellitus criteria in 2010 using HbA1c. Diabetol Int2013;4:9–15. https://link.springer.com/article/10.1007/s13340-012-0086-7.

Kowall B, Rathmann W. HbA1c for diagnosis of type 2 diabetes. Is there an optimal cut point to assess high risk of diabetes complications, and how well does the 6.5% cut off perform? Diabetes Metab Syndr Obes 2013; 6:477–91.

Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardio-vascular risk in nondiabetic adults. N Engl J Med 2010; 362:800–11.

International Diabetes Federation. Report of a World Health Organization Consultation. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Diabetes Res Clin Pract 2011; 93:299–309.http://www.diabetesresearchclinicalpractice.com/article/S0168-8227(11)00131-8/pdf.

Nielsen AA, Petersen PH, Green A, et al. Changing from glucose to HbA1c for diabetes diagnosis: Predictive values of one test and importance of analytical bias and imprecision. Clin Chem Lab Med 2014; 52:1069–77.

Rosella LC, Lebenbaum M, Fitzpatrick T, et al. Prevalence of prediabetes and undiagnosed diabetes in Canada (2007–2011) according to fasting plasma glucose and HbA1c screening criteria. Diabetes Care 2015; 38:1299–305.

Karnchanasorn R, Huang J, Ou HY, et al. Comparison of the current diagnostic criterion of HbA1c with fasting and 2-hour plasma glucose concentration. J Diabetes Res 2016; 2016:6195494.

Son JI, Rhee SY, Woo JT, et al. Hemoglobin A1c may be an inadequate diagnostic tool for diabetes mellitus in anemic subjects. Diabetes Metab J2013; 37:343–8.

Attard SM, Herring AH, Wang H, et al. Implications of iron deficiency/anemia on the classification of diabetes using HbA1c. Nutr Diabetes 2015; 5: e166.

Cavagnolli G, Pimentel AL, Freitas PA, et al. Factors affecting A1C in non-diabetic individuals: Review and meta-analysis. Clin Chim Acta 2015; 445:107–14.

Bazo-Alvarez JC, Quispe R, Pillay TD, et al. Glycated haemoglobin (HbA1c) and fasting plasma glucose relationships in sea-level and high-altitude settings. Diabet Med 2017; 34:804–12.

Carson AP, Muntner P, Selvin E, et al. Do glycemic marker levels vary by race? Differing results from a cross-sectional analysis of individuals with and without diagnosed diabetes. BMJ Open Diabetes Res Care 2016;4: e000213.

Cavagnolli G, Pimentel AL, Freitas PA, et al. Effect of ethnicity on HbA1c levels in individuals without diabetes: Systematic review and meta-analysis. PLoS ONE2017;12: e0171315.

Tsugawa Y, Mukamal KJ, Davis RB, et al. Should the hemoglobin A1c diagnostic cutoff differ between blacks and whites? A cross-sectional study. Ann Intern Med 2012; 157:153–9.

Davidson MB, Schriger DL. Effect of age and race/ethnicity on HbA1c levels in people without known diabetes mellitus: Implications for the diagnosis of diabetes. Diabetes Res Clin Pract 2010; 87:415–21.

Sacks DB. A1C versus glucose testing: A comparison. Diabetes Care 2011; 34:518.

Christophi CA, Resnick HE, Ratner RE, et al. Confirming glycemic status in the Diabetes Prevention Program: Implications for diagnosing diabetes in high risk adults. J Diabetes Complications 2013; 27:150–7.

Huang Y, Cai X, Mai W, et al. Association between prediabetes and risk of cardiovascular disease and all cause mortality: Systematic review and meta-analysis. BMJ 2016; 355: i5953.

Warren B, Pankow JS, Matsushita K, et al. Comparative prognostic performance of definitions of prediabetes: A prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. Lancet Diabetes Endocrinol 2016; 5:34–42.

Zhang X, Gregg EW, Williamson DF, et al. A1C level and future risk of diabetes: A systematic review. Diabetes Care 2010; 33:1665–73.

Heianza Y, Arase Y, Fujihara K, et al. Screening for pre-diabetes to predict future diabetes using various cut-off points for HbA(1c) and impaired fasting glucose: The Toranomon Hospital Health Management Center Study 4 (TOPICS 4). Diabet Med 2012; 29: e279–85.

Colagiuri S, Lee CM, Wong TY, et al. Glycemic thresholds for diabetes-specificretinopathy: Implications for diagnostic criteria for diabetes. Diabetes Care2011; 34:145–50.

Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med 2009; 6: e1000097.